Sato Hiroshi, Yoshida Masahito, Murase Hayato, Nakagawa Hiroshi, Doi Takayuki
Graduate School of Pharmaceutical Sciences, Tohoku University , 6-3 Aza-Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.
Mitsubishi Tanabe Pharma Corporation , 3-2-10, Dosho-machi, Chuo-ku, Osaka 541-8505, Japan.
ACS Comb Sci. 2016 Sep 12;18(9):590-5. doi: 10.1021/acscombsci.6b00076. Epub 2016 Aug 18.
Combinatorial synthesis and biological evaluation of cyclodepsipeptide destruxin B have been achieved. The cyclization precursors were prepared by solid-phase peptide synthesis via a split and pool method utilizing SynPhase lanterns with colored tags and cogs, followed by cleavage from the polymer-support. Macrolactonization utilizing MNBA-DMAPO in solution-phase was successfully performed in parallel to afford the desired 64-member destruxin analogues in moderate to good yields. Biological evaluation of the synthesized analogues indicated that a MeAla residue for the building block A is required to induce the desired morphological changes in osteoclast-like multinuclear cells (OCLs), and introduction of the substituent at the R(4) position of a proline moiety is tolerated by the morphology and may enable the preparation of a molecular probe for the target identification in the osteoclasts.
环缩肽毁灭菌素B的组合合成及生物学评价已完成。环化前体通过固相肽合成法,采用带有彩色标签和嵌齿的SynPhase灯笼,经分割与混合法制备,随后从聚合物载体上裂解下来。在溶液相中利用MNBA-DMAPO成功并行进行大环内酯化反应,以中等至良好的产率得到所需的64元毁灭菌素类似物。对合成类似物的生物学评价表明,构建模块A中的MeAla残基是诱导破骨细胞样多核细胞(OCLs)产生所需形态变化所必需的,并且脯氨酸部分R(4)位引入取代基在形态上是可耐受的,这可能有助于制备用于破骨细胞中靶点识别的分子探针。